MediFind
Condition

Adrenocortical Carcinoma

Symptoms, Doctors, Treatments, Research & More

Active Clinical Trials

Clinical Trial
Other
  • Status: Enrolling by invitation
  • Participants: 1000
  • Start Date: November 10, 2020
Retrospective Study of Optimal Methods of Disease Progression and Survival Analysis in Children and Adults With Adrenocortical Cancer (ACC)
Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 43
  • Start Date: April 1, 2020
Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 37
  • Start Date: June 4, 2019
Phase II Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable/Metastatic Adrenocortical Carcinoma
Clinical Trial
Drug
  • Status: Enrolling by invitation
  • Study Type: Drug
  • Participants: 75
  • Start Date: May 7, 2018
An Open-Label Extension Study of the Safety of Relacorilant in the Treatment of the Signs and Symptoms of Cushing Syndrome
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 18
  • Start Date: February 26, 2018
A Phase II Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable/Metastatic Adrenocortical Carcinoma
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 57
  • Start Date: December 28, 2017
A Phase II Study of Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: September 22, 2017
Phase II Trial of Surgical Resection and Heated Intraperitoneal Peritoneal Chemotherapy (HIPEC) for Adrenocortical Carcinoma